Refine
Has Fulltext
- yes (18)
Is part of the Bibliography
- yes (18)
Year of publication
Document Type
- Journal article (18)
Language
- English (18)
Keywords
- ABCG2 (1)
- ABL gene (1)
- Aspergillus (1)
- Axonal degeneration (1)
- B-MYB (1)
- BAL (1)
- Biomarker (1)
- Bombus Spp. Hymenoptera (1)
- CML (1)
- COVID-19 (1)
- Chronic myeloid leukaemia (1)
- Diabetic polyneuropathy (1)
- Epstein-Barr virus (1)
- Imatinib (1)
- Medizin (1)
- Mexican coffee plantations (1)
- Molecularly targeted therapy (1)
- Motor nerve biopsy (1)
- Myb-MuvB (1)
- Neuropathy (1)
- Neurotrophic factors (1)
- Northeastern Costa Rica (1)
- Organoids (1)
- PCR (1)
- Prediction (1)
- RQQ domain (1)
- Risk factors (1)
- SARS-CoV (1)
- T1 (1)
- Translational research (1)
- YAP (1)
- androgen deprivation therapy (1)
- antifungal (1)
- aquaporin 3 protein (1)
- aspergillosis (1)
- atraumatic surgery (1)
- autoimmunity (1)
- bacillus calmette guerin (1)
- binding protein (1)
- bird species richness (1)
- blood (1)
- bone mineral density (1)
- breakpoint (1)
- bumblebee nest density (1)
- cancer genomics (1)
- cancers and neoplasms (1)
- cerebrospinal fluid (1)
- chronic myelogenous leukemia (1)
- chronic myeloid leukemia (1)
- chronic phase (1)
- cochlear implants (1)
- comparison (1)
- complex (1)
- cytogenetic response (1)
- data sharing (1)
- decay (1)
- degradation (1)
- different imatinib dose regimens (1)
- dung beetle coleoptera (1)
- early applied higher imatinib dosages (1)
- electric acoustic stimulation (EAS) (1)
- enhancer (1)
- ephitelial cells (1)
- epigenetics in the nervous system (1)
- epigenomics (1)
- epithelium (1)
- failure load (1)
- flow cytometry (1)
- follow up (1)
- gastrointestinal infections (1)
- gene expression (1)
- global change (1)
- growth (1)
- habitat destruction (1)
- hearing preservation (1)
- hip fracture (1)
- hybrid messenger RNA (1)
- identification (1)
- immunohistochemistry (1)
- in vitro (1)
- instensively managed farmland (1)
- land use (1)
- land-use change (1)
- large gene lists (1)
- lymph node metastases (1)
- mechanical torque measurement (1)
- metastasis-directed therapy (1)
- mitotic genes (1)
- motifs (1)
- neurocritical care (1)
- neurological disorders (1)
- no correlation (1)
- older patients (1)
- oligmometastases (1)
- oligorecurrence (1)
- oncogenesis (1)
- osteoporosis (1)
- paediatric cancer (1)
- pandemic (1)
- partial deafness treatment (1)
- patient triage (1)
- plant community composition (1)
- polymerase-chain-reaktion (1)
- predictive markers (1)
- progression (1)
- proliferation (1)
- prostate cancer (1)
- psychiatry (1)
- radiation therapy (1)
- recurrence (1)
- stage pT1 (1)
- stereotactic body radiotherapy (1)
- stress (1)
- survival (1)
- transcription (1)
- transcripts (1)
- transitional cell carcinoma (1)
- translational research (1)
- tumor (1)
- urban-rural gradient (1)
- urothelial bladder carcinoma (1)
- water channels (1)
Institute
- Medizinische Klinik und Poliklinik II (7)
- Theodor-Boveri-Institut für Biowissenschaften (5)
- Pathologisches Institut (3)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Neurologische Klinik und Poliklinik (2)
- Comprehensive Cancer Center Mainfranken (1)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Frauenklinik und Poliklinik (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Virologie und Immunbiologie (1)
Sonstige beteiligte Institutionen
Pan-cancer analyses that examine commonalities and differences among various cancer types have emerged as a powerful way to obtain novel insights into cancer biology. Here we present a comprehensive analysis of genetic alterations in a pan-cancer cohort including 961 tumours from children, adolescents, and young adults, comprising 24 distinct molecular types of cancer. Using a standardized workflow, we identified marked differences in terms of mutation frequency and significantly mutated genes in comparison to previously analysed adult cancers. Genetic alterations in 149 putative cancer driver genes separate the tumours into two classes: small mutation and structural/copy-number variant (correlating with germline variants). Structural variants, hyperdiploidy, and chromothripsis are linked to TP53 mutation status and mutational signatures. Our data suggest that 7–8% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.